Detection of human cytomegalovirus DNA by real-time quantitative PCR

被引：45

作者：

Nitsche, A

Steuer, N

Schmidt, CA

Landt, O

Ellerbrok, H

Pauli, G

Siegert, W

机构：

[1] Humboldt Univ, Klin Innere Med MS Hamatol & Onkol, D-13353 Berlin, Germany

[2] Robert Koch Inst, TIB Molbiol, D-1000 Berlin, Germany

[3] Robert Koch Inst, Dept Virol, D-1000 Berlin, Germany

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2000年 / 38卷 / 07期

关键词：

D O I：

10.1128/JCM.38.7.2734-2737.2000

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A real-time PCR assay was developed to quantify human cytomegalovirus (CMV) DNA. This assay was used to demonstrate a higher CMV DNA load in plasma of bone marrow transplant patients than in that of blood donors. The CMV load was higher in CMV antigen-positive patients than in antigen-negative patients.

引用

收藏

页码：2734 / 2737

页数：4

相关论文

共 16 条

[1] Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects [J].

Boivin, G ;

Handfield, J ;

Toma, E ;

Murray, G ;

Lalonde, R ;

Tevere, VJ ;

Sun, R ;

Bergeron, MG .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (09) :2509-2513

[2]

DUMMER JS, 1990, REV INFECT DIS, V12, pS767

[3] TREATMENT OF INVASIVE CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT PATIENTS WITH GANCICLOVIR [J].

DUNN, DL ;

MAYORAL, JL ;

GILLINGHAM, KJ ;

LOEFFLER, CM ;

BRAYMAN, KL ;

KRAMER, MA ;

ERICE, A ;

BALFOUR, HH ;

FLETCHER, CV ;

BOLMAN, RM ;

MATAS, AJ ;

PAYNE, WD ;

SUTHERLAND, DER ;

NAJARIAN, JS .

TRANSPLANTATION, 1991, 51 (01) :98-106

[4] EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].

GOODRICH, JM ;

MORI, M ;

GLEAVES, CA ;

DUMOND, C ;

CAYS, M ;

EBELING, DF ;

BUHLES, WC ;

DEARMOND, B ;

MEYERS, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1601-1607

[5] Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease [J].

Gor, D ;

Sabin, C ;

Prentice, HG ;

Vyas, N ;

Man, S ;

Griffiths, PD ;

Emery, VC .

BONE MARROW TRANSPLANTATION, 1998, 21 (06) :597-605

[6] GANCICLOVIR THERAPY OF SEVERE CYTOMEGALO-VIRUS INFECTIONS IN SOLID-ORGAN TRANSPLANT RECIPIENTS [J].

HARBISON, MA ;

DEGIROLAMI, PC ;

JENKINS, RL ;

HAMMER, SM .

TRANSPLANTATION, 1988, 46 (01) :82-88

[7] DETECTION OF SPECIFIC POLYMERASE CHAIN-REACTION PRODUCT BY UTILIZING THE 5'-]3' EXONUCLEASE ACTIVITY OF THERMUS-AQUATICUS DNA-POLYMERASE [J].

HOLLAND, PM ;

ABRAMSON, RD ;

WATSON, R ;

GELFAND, DH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7276-7280

[8] Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time [J].

Larsson, S ;

Söderberg-Nauclér, C ;

Wang, FZ ;

Möller, E .

TRANSFUSION, 1998, 38 (03) :271-278

[9]

Nitsche A, 1999, CLIN CHEM, V45, P1932

[10] Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients [J].

Roberts, TC ;

Brennan, DC ;

Buller, RS ;

Gaudreault-Keener, M ;

Schnitzler, MA ;

Sternhell, KE ;

Garlock, KA ;

Singer, GG ;

Storch, GA .

JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) :626-635